Takashi Nagamachi

71 year

Health Technology

Consumer Non-Durables

Consumer Services

Profile

Mr. Takashi Nagamachi is President at Ajinomoto Pharmaceuticals Co., Ltd.
He is on the Board of Directors at Ajinomoto Co., Inc. He received his undergraduate degree from Keio University.

Former positions of Takashi Nagamachi

Companies	Position	End
AJINOMOTO CO., INC.	Director/Board Member	-
EA Pharma Co., Ltd. EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business.	Chief Executive Officer	-

See the detail of Takashi Nagamachi's experience

Training of Takashi Nagamachi

Keio University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Takashi Nagamachi's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AJINOMOTO CO., INC.	Consumer Non-Durables

Private companies	1
EA Pharma Co., Ltd. EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business.	Health Technology